NKTR-214 Shows Activity in Phase I RCC Study

Changing gut microbiome improves outcomes for people newly diagnosed with metastatic kidney cancer in phase I study

People with metastatic kidney cancer who orally took a live biotherapeutic product called CBM588 while in treatment with immunotherapy and enzymatic tyrosine kinase inhibitors experienced improved health outcomes, according to research from City of Hope.

July 05, 2024

Vol.50 No.27

Clinical Roundup

Cells in tumor microenvironment play critical role in effectiveness of rapalogs

For nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Now, a study by researchers at UT Southwestern Medical Center’s Kidney Cancer Program sheds light.

June 14, 2024

Vol.50 No.24

Funding Opportunities

DOD Kidney Cancer Research Program funding opportunities for FY24

The FY24 Defense Appropriations Act provides funding for the Kidney Cancer Research Program to support research of exceptional scientific merit in the area of kidney cancer.

April 19, 2024

Vol.50 No.16

In Brief

Nobel Laureate William Kaelin receives Fox Chases’s Stanley P. Reimann Honor Award

Jonathan Chernoff and William G. KaelinWilliam G. Kaelin Jr., physician, scientist, and Nobel laureate, was recognized at Fox Chase Cancer Center with the Stanley P. Reimann Honor Award, the center’s highest distinction.

April 05, 2024

Vol.50 No.14

In Brief

Maria Czyzyk-Krzeska awarded $2.3M NIH grant to study copper effects on kidney cancer

The University of Cincinnati Cancer Center’s Maria F. Czyzyk-Krzeska was awarded a five-year, $2.8 million grant from the NIH to investigate how copper contributes to the advancement and recurrence of the most common type of kidney cancer, clear cell renal cell carcinoma.

January 19, 2024

Vol.50 No.03

In Brief

Alexander Kutikov to receive Andrew C. Novick Award at International Kidney Cancer Symposium

Alexander Kutikov, chair of the Department of Urology and the Roberta R. Scheller Chair in Urologic Oncology at Fox Chase Cancer Center, will receive the Andrew C. Novick Award from the Kidney Cancer Association.

November 10, 2023

Vol.49 No.42

NKTR-214 Shows Activity in Phase I RCC Study

YOU MAY BE INTERESTED IN

Changing gut microbiome improves outcomes for people newly diagnosed with metastatic kidney cancer in phase I study

Cells in tumor microenvironment play critical role in effectiveness of rapalogs

DOD Kidney Cancer Research Program funding opportunities for FY24

Nobel Laureate William Kaelin receives Fox Chases’s Stanley P. Reimann Honor Award

Maria Czyzyk-Krzeska awarded $2.3M NIH grant to study copper effects on kidney cancer

Alexander Kutikov to receive Andrew C. Novick Award at International Kidney Cancer Symposium

Renew today!

Subscriber content

Login